How Big Is the Hereditary Cancer Screening Market | Insights & Forecasts 2026

Q: What is the current size of the hereditary cancer screening market?

It was valued at USD 4.3 billion in 2025 and is expected to reach USD 10.1 billion by 2032.

Q: What is the market’s growth rate?

The market is projected to grow at a CAGR of 12.9% from 2026 to 2032.

Q: Which technologies are widely used?

Next-generation sequencing (NGS), PCR, and microarray technologies.

Q: Which cancers are commonly screened?

Breast, ovarian, colorectal, prostate, and pancreatic cancers.

Q: What challenges affect the market?

High test costs, limited awareness in developing regions, and data privacy concerns.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA6154

Publication Date: Jul 2025

How big is the Hereditary Cancer Screening Market?

According to 6Wresearch internal database and industry insights, the Hereditary Cancer Screening Market was valued at USD 4.3 Billion in 2025 and is projected to reach USD 10.1 Billion by 2032, growing at a CAGR of 12.9% during the forecast period of 2026–2032.

The market is growing due to increasing awareness of genetic disorders, demand for early cancer detection, and advancements in next-gen sequencing technologies.

Key Growth Drivers of the Hereditary Cancer Screening Market

Rising incidence of breast, ovarian, and colorectal cancers
Advancements in next-generation sequencing and genetic diagnostics
Growing awareness of genetic risk factors and preventive screening
Favorable government initiatives and reimbursement policies
Increasing adoption of personalized medicine and early detection

Hereditary Cancer Screening Market Trends

Thehereditary cancer screening marketis witnessing rising demand for multi-gene panel testing over single-gene tests. Direct-to-consumer genetic testing services are gaining popularity, especially in developed regions. Integration of AI and bioinformatics is enhancing the accuracy of predictive diagnostics. Partnerships between diagnostic labs and pharma companies are increasing to deliver companion diagnostics. Awareness campaigns and genetic counseling services are expanding access across emerging markets.

Emerging Developments in the Hereditary Cancer Screening Market

Hereditarycancer screening market witnessed a breakthrough in innovation as liquid biopsy techniques are used to detect genetic mutations on a non-invasive basis, using samples of blood. Genetic information on complex data is also being analyzed through AI-based analytical software which enhances diagnostic accuracy, risk stratification of the patients. Firms are also increasing their list of hereditary cancer test panels with uncommon syndromes such as Lynch and Li-Fraumeni. Testing is becoming more available, particularly in less served regions, due to the possibility of collecting the samples remotely and tele-genetic counseling.